TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
VTGN

VistaGen Therapeutics Inc

Healthcare · Biotechnology

0.3684$ +46.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

VistaGen Therapeutics Inc (VTGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 36 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VTGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
42 131 124 114 102 92 84 69 81 65 49 36
39 128 121 111 100 90 82 67 79 63 47 34
38 127 119 103 84 75 67 49 63 47 31 17
38 127 119 108 98 89 80 63 77 62 45 32
6.6 7.8 9.4 8.7 9.5 11 14 12 15 14 13 11
2.9 4.2 5.1 6.2 7.5 9.6 13 11 14 14 13 11
0.5 0.5 0.6 0.6 0.5 0.6 0.6 1.6 1.3 1.0 0.8 0.7
1.3 1.7 1.5 1.2 0.7 1.0 0.7 0.5 1.8 1.3 1.5 1.0
36 123 114 105 93 81 70 57 66 51 36 24
-340 -347 -356 -367 -380 -394 -408 -423 -442 -461 -477 -490
10 29 27 31 31 31 31 32 36 42 40 43

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?